Anavex Life Sciences Corp (AVXL)
4.55
+0.05
(+1.11%)
USD |
NASDAQ |
May 17, 16:00
4.545
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Shareholders Equity (Quarterly): 134.96M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 134.96M |
December 31, 2023 | 135.58M |
September 30, 2023 | 141.85M |
June 30, 2023 | 146.75M |
March 31, 2023 | 145.17M |
December 31, 2022 | 135.12M |
September 30, 2022 | 142.49M |
June 30, 2022 | 150.74M |
March 31, 2022 | 152.20M |
December 31, 2021 | 146.37M |
September 30, 2021 | 150.82M |
June 30, 2021 | 157.15M |
March 31, 2021 | 75.81M |
December 31, 2020 | 46.30M |
September 30, 2020 | 27.24M |
June 30, 2020 | 24.68M |
March 31, 2020 | 24.79M |
December 31, 2019 | 25.96M |
September 30, 2019 | 20.29M |
June 30, 2019 | 17.63M |
March 31, 2019 | 14.18M |
December 31, 2018 | 17.22M |
September 30, 2018 | 22.32M |
June 30, 2018 | 23.59M |
March 31, 2018 | 22.48M |
Date | Value |
---|---|
December 31, 2017 | 25.55M |
September 30, 2017 | 24.25M |
June 30, 2017 | 23.45M |
March 31, 2017 | 21.49M |
December 31, 2016 | 19.18M |
September 30, 2016 | 6.308M |
June 30, 2016 | 7.671M |
March 31, 2016 | 9.683M |
December 31, 2015 | 11.49M |
September 30, 2015 | 12.81M |
June 30, 2015 | 6.569M |
March 31, 2015 | 4.702M |
December 31, 2014 | 0.4731M |
September 30, 2014 | 0.1926M |
June 30, 2014 | 7.409M |
March 31, 2014 | 8.408M |
December 31, 2013 | -1.670M |
September 30, 2013 | -2.463M |
June 30, 2013 | -3.553M |
March 31, 2013 | -3.435M |
December 31, 2012 | -3.329M |
September 30, 2012 | -2.875M |
June 30, 2012 | -2.198M |
March 31, 2012 | -2.928M |
December 31, 2011 | -2.481M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
17.63M
Minimum
Jun 2019
157.15M
Maximum
Jun 2021
100.09M
Average
135.35M
Median
Shareholders Equity (Quarterly) Benchmarks
Ventyx Biosciences Inc | 307.00M |
Checkpoint Therapeutics Inc | -10.25M |
Amicus Therapeutics Inc | 130.69M |
Insmed Inc | -464.81M |
InfuSystems Holdings Inc | 52.28M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 144.52M |
Total Liabilities (Quarterly) | 9.558M |